Pfizer to buy Seagen for $43 billion to fortify cancer portfolio
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Drugs
Medical
Pharma
Drugs
Medical
Pharma
Merck says trial hypertension drug enhances patients’ walk time
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.
Health
Pharma
World Bank loans India $1 billion to aid healthcare sector
The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south.
Drugs
Medical
Pharma
CDC report points finger at Indian firm in Gambia deaths
A probe by the US-based Centres for Disease Control into the deaths of 70 children in Gambia "strongly suggests" cough syrups involving contaminated.
Drugs
Pharma
FDA rejects Cytokinetics heart disease trial drug
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems.
Drugs
Health
Pharma
Australian boffins make device to detect cancer from bloodstream
A device, which uses a unique metabolic signature of cancer, differentiates tumor cells from normal blood cells without biopsy, according to Australian researchers.
Drugs
Health
Pharma
Iceland tops list of antidepressant drug users in Europe
Antidepressant drug consumption is on the rise in Europe, and Iceland tops the list, followed by Portugal and the UK, according to the.
Drugs
Pharma
FDA nod for Granules India’s drug to treat high blood pressure
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets.
Drugs
Health
Pharma
Global avian influenza is ‘worrying’: WHO, Cambodia reports girl’s death
The global H5N1 situation is "worrying," and the WHO is investigating reports of death and a confirmed case in a family in Cambodia.
Drugs
Pharma
FDA closes inspection of Strides Pharma’s Bangalore unit
The USFDA has closed an inspection of India’s Strides Pharma Science in southern Bangalore, which serves markets in the US, Europe and Australia,.